| Liu, Bin |
NCT05312268: Rasburicase Treatment in Chronic Gouty Arthritis |
|
|
| Recruiting | 4 | 60 | RoW | Rasburicase | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Chronic Gout | 10/24 | 04/25 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
public, NCT06162286: A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP |
|
|
| Recruiting | 3 | 100 | RoW | Omadacycline, Moxifloxacin | Zai Lab (Hong Kong), Ltd. | Community-acquired Bacterial Pneumonia | 01/25 | 11/25 | | |
NCT06635798: A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection |
|
|
| Recruiting | 3 | 582 | RoW | GR2001, HTIG | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Tetanus | 12/24 | 03/25 | | |
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. |
|
|
| Recruiting | 2/3 | 216 | RoW | B007, Cyclosporin Capsules | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Primary Membranous Nephropathy | 12/26 | 12/26 | | |
TQC3721-II-03, NCT06527144: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease |
|
|
| Recruiting | 2 | 240 | RoW | 3mg TQC3721 Suspension for Inhalation, 6mg TQC3721 Suspension for Inhalation, Placebo TQC3721 suspension for inhalation | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pulmonary Disease, Chronic Obstructive | 02/25 | 12/25 | | |
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke |
|
|
| Recruiting | 2 | 300 | RoW | LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose | Shanghai Pharmaceuticals Holding Co., Ltd | Acute Ischemic Stroke | 04/25 | 07/25 | | |
NCT05150405: A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors |
|
|
| Recruiting | 1 | 54 | RoW | QLF31907 | Qilu Pharmaceutical Co., Ltd. | Solid Tumor, Lymphoma, Non-Hodgkin | 03/24 | 06/24 | | |
NCT04966143: Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer |
|
|
| Recruiting | 1 | 30 | RoW | LY011 | Shanghai Longyao Biotechnology Inc., Ltd. | Pancreatic Cancer | 08/23 | 08/24 | | |
| Recruiting | N/A | 4500 | RoW | | Harbin Medical University, Abbott | Acute Myocardial Infarction | 07/21 | 12/22 | | |
NCT04569669: The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis |
|
|
| Not yet recruiting | N/A | 325 | RoW | FFR and FFRCT | CCRF Inc., Beijing, China, Shengshi Technology, Co., Ltd, Hangzhou, China | Coronary Stenosis | 10/21 | 03/22 | | |
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis |
|
|
| Completed | N/A | 260 | RoW | drug-coated balloon Catheter | B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease, In Stent Restenosis | 07/22 | 08/22 | | |
NCT04953117: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease |
|
|
| Recruiting | N/A | 286 | RoW | DCB of Lepu Medical(dimeter≥2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary small vessels, Restore DEB, RESTORE Paclitaxel releasing coronary balloon catheter, DCB of Lepu Medical(dimeter<2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary very small vessels | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease | 06/22 | 04/23 | | |
NCT06158425: Constitutional Alignment in Osteoarthritic and Healthy Chinese |
|
|
| Recruiting | N/A | 353 | RoW | long-leg radiograph | The First Hospital of Jilin University | Osteoarthritis, Knee | 11/23 | 12/23 | | |
NCT04474860: Gene Mutation Spectrum of Malignant Hyperthermia in China |
|
|
| Recruiting | N/A | 200 | RoW | gene sequencing | West China Hospital | Malignant Hyperthermia | 01/24 | 01/24 | | |
NCT06357026: Phitys I™ Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 344 | RoW | Percutaneous Ventricular Assist System（Phigine Medical）, intra-aortic balloon pump (IABP) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 05/25 | 04/26 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
NCT06639321: Phimume® Percutaneous Left Ventricular Assist System Study |
|
|
| Not yet recruiting | N/A | 250 | RoW | Percutaneous Ventricular Assist System, extracorporeal membrane oxygenation (ECMO) | Shanghai NewMed Medical Co., Ltd., Shanghai Phigine Medical Technology Co., Ltd. | Coronary Artery Disease | 11/25 | 10/26 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
NCT05715138: Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia |
|
|
| Not yet recruiting | N/A | 98 | RoW | GPi-DBS, STN-DBS, GPi-DBS devices, STN-DBS devices | Chinese PLA General Hospital | Cervical Dystonia | 12/24 | 11/26 | | |
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort |
|
|
| Recruiting | N/A | 15000 | RoW | Treatment Strategies | Yu Bo | Acute Myocardial Infarction, Adverse Event | 08/25 | 12/26 | | |
NCT05968248: Efficacy and Safety of Deep Brain Stimulation in Mesencephalic Locomotor Region（MLR） for Poststroke Hemiplegia |
|
|
| Not yet recruiting | N/A | 62 | NA | MLR-DBS, Conventional rehabilitation group | Chinese PLA General Hospital | Stroke Sequelae | 12/25 | 11/27 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT06121947: Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia |
|
|
| Not yet recruiting | N/A | 98 | RoW | The DBS electrodes are implanted into MLR., The electrodes are implanted into the patient's vagus nerve | Chinese PLA General Hospital | Stroke Sequelae, Deep Brain Stimulation, Vagus Nerve Stimulation, Motor Recovery, Stroke, Hemiplegia | 10/29 | 10/30 | | |
NCT04451967: Acute Myocardial Infarction Study in Northeastern China |
|
|
| Recruiting | N/A | 3159 | RoW | thrombolysis, DAPT | Second Hospital of Jilin University, Yanbian University Hospital, Dunhua City Hospital in Jilin Province, Liaoyuan City Central Hospital, Dongliao People's Hospital, Songyuan Central Hospital, Changling People's Hospital, Siping Central Hospital, The First People's Hospital of Manchu Autonomous County, Changchun Center Hospital, Nongan People's Hospital, Beihua University, Jilin Hospital of Integrated Traditional Chinese and Western Medicine, Panshi City Hospital, Tonghua Central Hospital, Baishan Central Hospital, Jingyu People's Hospital, Meihekou Central Hospital, Baicheng Central Hospital, Tongyu First Hospital | Acute Myocardial Infarction | 09/20 | 09/22 | | |
| Wang, He |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. |
|
|
| Recruiting | 2 | 90 | RoW | B013, Paclitaxel, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Platinum-resistant Recurrent Ovarian Cancer | 12/26 | 12/26 | | |
NCT06308406: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer |
|
|
| Recruiting | 1/2 | 54 | RoW | Bevacizumab； HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Recurrent Ovarian Cancer | 10/25 | 10/25 | | |
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 153 | RoW | HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Solid Tumors | 12/24 | 12/24 | | |
NCT04451967: Acute Myocardial Infarction Study in Northeastern China |
|
|
| Recruiting | N/A | 3159 | RoW | thrombolysis, DAPT | Second Hospital of Jilin University, Yanbian University Hospital, Dunhua City Hospital in Jilin Province, Liaoyuan City Central Hospital, Dongliao People's Hospital, Songyuan Central Hospital, Changling People's Hospital, Siping Central Hospital, The First People's Hospital of Manchu Autonomous County, Changchun Center Hospital, Nongan People's Hospital, Beihua University, Jilin Hospital of Integrated Traditional Chinese and Western Medicine, Panshi City Hospital, Tonghua Central Hospital, Baishan Central Hospital, Jingyu People's Hospital, Meihekou Central Hospital, Baicheng Central Hospital, Tongyu First Hospital | Acute Myocardial Infarction | 09/20 | 09/22 | | |
| Zhang, Shan |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
